Book summary “Drugs, the brain and behavior”: summary

Introduction

You often wonder how chemical substances can completely transform your thoughts, moods, and actions. For centuries, thinkers struggled to explain the connection between the physical brain and the intangible mind. This separation left you without clear answers regarding why drugs exert such powerful control over human behavior. John Brick bridges this gap in Drugs, the brain and behavior by exploring the biological basis of mental life.

Psychoactive drugs alter human thoughts, feelings, and behavior by directly changing brain chemistry and functioning.

The book guides you through the complex machinery of the nervous system, tracing how foreign molecules cross biological barriers to modify neural communication. You learn the core principles of pharmacokinetics, examine specific drug classes from alcohol to hallucinogens, and analyze the mechanisms of addiction and forensic toxicology.

• How do psychoactive chemicals cross the blood-brain barrier?
• What distinguishes a depressant from a stimulant at the cellular level?
• Why do certain substances trigger powerful chemical dependence while others do not?

1. Foundations of Psychopharmacology and Action

Psychoactive chemicals alter behavior by acting as environmental stimuli that trigger brain cell receptors.

Psychoactive drugs are chemicals that alter human thoughts, feelings, and behavior by directly changing brain functioning. While general drugs are therapeutic chemicals designed for maximum benefit and minimal risk, psychoactive drugs specifically produce their behavioral effects by modifying brain chemistry.

• Alcohol
• Heroin
• Caffeine
• Prozac

Antibiotics are also drugs, but they are not psychoactive because they target infections rather than altering mental state directly. You encounter these distinctions when examining prescriptive drugs that possess multiple naming conventions.

Drug Definitions and Naming Conventions

Distinguishing between naming conventions is vital for clarity. Brand names are proper nouns and must always be capitalized, whereas generic drug names serve as common nouns and remain uncapitalized.

The antianxiety medication Xanax serves as an example. Xanax is the brand name, alprazolam is the generic name, C17H13ClN4 is the molecular formula, and 8-Chloro-1-methyl-6-phenyl-4Hs-triazolo [4, -delta] [1,4] benzodiazepine is the chemical name.

The BBB Model of Drug Action

Brick's Big Bang model explains that psychoactive drugs act as environmental stimuli that trigger brain cell receptors, altering mental state and behavior. The model consists of three components: a stimulus, a sensory receptor system, and a response.

• Stimulus (S)
• Sensory receptor system (SRS)
• Response (R)

Psychoactive drugs act as the stimulus, while receptors located on cells within the brain act as the receptor system, changing thoughts and feelings upon activation.

An external explosion like a cherry bomb acts as a sensory stimulus causing autonomic responses such as dilated pupils and elevated heart rate. This mirrors how a stimulant drug acts on brain receptors to alter physiology.

From Mind-Body Dualism to Neural Control

Historical views of the brain evolved from treating the mind and body as separate, interacting entities to recognizing that the mind is entirely physical and rooted in nervous system activity. Philosophers like Aristotle and Descartes viewed the mind and body separately, with Descartes suggesting reflexes moved through animal spirits and interacted with the soul via the pineal gland. Later thinkers like Thomas Hobbes, John Locke, and David Hume established that consciousness and the mind are physical and derive from nervous system activity.

Case studies of localized brain damage proved that specific regions of the brain control complex behaviors such as speech and emotion. Paul Broca discovered through an autopsy that a patient unable to speak for 30 years had a lesion in the third convolution of the left frontal lobe, localizing speech.

Phineas Gage suffered an accidental explosion that launched an iron rod through his forehead. This destroyed his limbic system and transformed his personality from well-mannered to irritable.

Electrical stimulation of specific neural pathways demonstrates that reward circuitry in the brain drives compulsive self-stimulation and serves as a key substrate for addiction. James Olds and Peter Milner discovered that electrical stimulation of the brain, specifically targeting the medial forebrain bundle, produced a powerful rewarding effect.

James Olds and Peter Milner placed electrodes in rat brains where animals would press levers thousands of times per hour for electrical stimulation of the medial forebrain bundle to the exclusion of basic survival activities like eating or mating.

2. Neuroanatomy and Neurotransmission Mechanics

Nervous system organization and electrochemical signaling govern how drugs modify neurotransmitter activity.

The central nervous system consists of the brain and spinal cord, handling thinking and command signals. The peripheral nervous system includes the somatic nervous system for voluntary movement and the autonomic nervous system for involuntary functions, which is further split into sympathetic and parasympathetic branches that regulate homeostasis.

Nervous System Organization and Macro Structures

The adult human brain has an approximate weight of 1.600 grams or 3.5 pounds. The human brain contains 100 to 200 billion neurons alongside glial cells in a ratio of 10 to 1 in some brain areas. The unfolded cerebral cortex has an estimated surface area of 2 square meters.

The cerebral cortex manages sensory, motor, and cognitive functions across folded hemispheres connected by the corpus callosum. Subcortical structures like the cerebellum coordinate muscle timing, the brainstem manages vital survival reflexes and sleep cycles, the thalamus relays sensory signals, the hypothalamus maintains homeostasis, and the limbic system processes emotion and memory. Basal ganglia and cerebrospinal fluid also support these structures.

Neurophysiology and the Action Potential

Neurons communicate through electrochemical processes where resting electrical potentials shift via ion fluxes to trigger action potentials and release neurotransmitters. There are sixty identified neurotransmitters and forty-six identified receptor subtypes for psychoactive drug effects.

• Maintain resting membrane potential at negative seventy millivolts via ion distribution and pumps
• Alter membrane permeability to let sodium ions rush in and repel potassium ions
• Reach critical threshold to fire an action potential down the axon
• Move storage vesicles to cell membrane edge upon action potential arrival at axon terminal
• Release neurotransmitters into the synapse

Drug Mechanisms at the Synapse

All psychoactive drugs alter behavior by modifying the functional activity of neurotransmitters through specific cellular mechanisms at the synapse. Drugs change functional activity by increasing neurotransmitter release, directly activating or blocking receptors as agonists or antagonists, inhibiting neurotransmitter transport or reuptake, or inhibiting metabolizing enzymes that break down neurotransmitters.

3. Pharmacokinetics and Dose-Response Relationships

Pharmacokinetics governs how drugs enter the body, distribute through circulation, and leave it. This process directly determines the onset, strength, and duration of drug action.

Pharmacokinetics determines drug onset, strength, and duration through circulation, barrier crossing, and elimination.

A drug must enter circulation to have an effect. You rely on routes including oral administration, pulmonary inhalation, surface absorption, and injection.

You can trace the timeline of these different routes through specific entry speeds:

• less than 20 seconds for intravenous injection;
• 1 minute for the entire blood supply to make its way around the body;
• 15 to 30 minutes for solid drugs taken orally.

Factors such as water and lipid solubility, bioavailability, and binding to blood proteins dictate whether a drug can cross the blood-brain barrier to interact with brain tissue.

You process and clear the active substance through a defined sequence:

• Administer drug via oral, pulmonary, surface absorption, or injection route;
• Allow drug to cross membranes based on water and lipid solubility into capillaries;
• Transport drug through hepatic portal vein to liver and general circulation;
• Eliminate drug through metabolism, kidneys, breath, skin, or urine.

Dose-Response Curves and Safety Margins

Dose-response curves evaluate drug potency, efficacy, and safety margins by comparing effective therapeutic doses against lethal doses. High potency does not necessarily mean high safety. Drugs with steep dose-response slopes have narrow margins of safety where small dosage errors produce large toxic effects. Drug B requires only one-tenth of the dose compared to Drug C to produce the same effect.

The therapeutic index is the ratio between the lethal dose for 50 percent of the population and the effective dose for 50 percent of the population. This ratio indicates the safety margin of a drug.

You evaluate safety and effect using precise measurements:

• Establish dose-response curve to determine potency, slope, and efficacy;
• Calculate LD50 and ED50 values for the population;
• Determine the therapeutic index to assess the safety margin between effectiveness and toxicity.

4. Depressants, Alcohol, and Anxiolytics

Alcohol produces a dose-dependent biphasic effect on human behavior, acting first as an upper and then as a downer.

John Brick explains that alcohol operates as a central nervous system depressant that does not bind to a single specific receptor site in the body. As blood alcohol concentration rises, it induces a sequence of effects starting with decreased inhibitions, followed by psychomotor and cognitive impairments.

Several ounces represent the amount of methanol that can be lethal. Methanol is metabolized by the enzyme alcohol dehydrogenase into formic acid, a cellular toxin. Ethanol serves as an antidote because the enzyme oxidizes ethanol preferentially, allowing the unmetabolized methanol to be safely excreted with minimal formic acid formation.

• Always determine if there is a history of drinking anything other than beverage alcohol before treating a patient in a detox ward.

Under natural drinking conditions, 10 percent of orally ingested alcohol is absorbed through the stomach. The rate of absorption is primarily governed by stomach contents, beverage volume, and concentration. The presence of food in the stomach delays absorption, reduces gastric emptying time, and lowers the resulting blood alcohol concentration peak.

E. M. Widmark estimated total body water as the Rho factor, representing body weight percentages for men and women. Widmark's Rho factor is 0.68 for men and 0.58 for women. His reported beta rate of alcohol elimination is 15 mg/dL/hr or 0.015 percent/hr. Alcohol elimination typically follows a central tendency rate, dropping as a curved line at very low concentrations due to enzyme saturation.

Heavy alcohol consumption during pregnancy causes a continuum of permanent physical and cognitive defects known as fetal alcohol spectrum disorder. Ethanol easily crosses the placenta, and because fetal enzymes are immature, the fetus receives the full dose. Children with fetal alcohol syndrome exhibit distinct craniofacial abnormalities and lifelong intellectual or psychological impairment.

There are 3 to 4 children with estimated daily births with fetal alcohol syndrome in the United States. The proportion of children born with partial diagnoses is 10 to 15 times compared to classic fetal alcohol syndrome.

Benzodiazepines and GABA Enhancement

Benzodiazepines reduce anxiety by enhancing the functional activity of the inhibitory neurotransmitter gamma-aminobutyric acid.

Benzodiazepines bind to recognition proteins, blocking endogenous ligands like GABA modulin that normally inhibit GABA binding. This process increases chloride ion channel opening and hyperpolarizes the neuron. You will find that 9 percent of users experience chemical dependence on benzodiazepines.

Leo Sternbach synthesized heptodiazines in Krakow in the 1930s, later discovering their sedative properties at Hoffman La Roche and developing chlordiazepoxide, known as Librium, and diazepam, known as Valium. Benzodiazepines exhibit a 2 to 10 hours half-life for the initial phase and a 27 to 48 hours elimination half-life. A 1.0 mg therapeutic dose of alprazolam produces psychomotor impairment in about 84 percent of subjects.

Clinical guidelines for prescribing antianxiety medications emphasize combining pharmacotherapy with psychotherapy and avoiding unstructured as-needed usage. Because chronic anxiety requires careful regulation, clinicians should avoid irregular dosing and incorporate drug-free holidays to clear active metabolites.

• Identify life stressors precipitating anxiety that might be treated psychotherapeutically before prescribing.
• Explain that the drug is only part of the treatment when dealing with unalterable life events.
• Regulate doses for chronic anxiety rather than having the patient use the drug as needed.
• Combine drug use with psychotherapy rather than using medications as a replacement.
• Encourage drug-free holidays allowing a week or more to completely eliminate the drug and metabolites.

5. Stimulants, Nicotine, and Opioids

Stimulants, nicotine, and opioids hijack the mesolimbic dopamine reward pathway to produce euphoria and chemical dependence.

Cocaine and Sympathomimetic Stimulants

Cocaine binds to the dopamine transporter in the nucleus accumbens, preventing the removal of released dopamine. This keeps dopamine active in the synapse to trigger extreme well-being. The main effects of smoking crack cocaine last 5 to 10 minutes, while cocaine hydrochloride takes 15 to 30 minutes to reach peak effects.

As the most powerful xanthine stimulant, caffeine produces mild sympathomimetic effects. It blocks adenosine receptors and may inhibit phosphodiesterase to increase available cyclic AMP.

Chronic heavy use causes anhedonia, rebound sleep, and severe emotional depression. Long-term risks include stroke, hypertension, involuntary choreiform movements, and nasal septum perforation.

Nicotine Alkaloids and Pharmacokinetics

Nicotine is a volatile alkaline substance that acts as both a stimulant and depressant. It activates and desensitizes nicotinic acetylcholine receptors, leading to elevated dopamine in the mesolimbic dopamine system. About 32 percent of smokers become chemically dependent. In 2007, an estimated 20 percent of US adult cigarette smokers consumed tobacco. Worldwide, tobacco causes 5 million deaths annually, while the United States records 440,000 annual deaths.

Smokers with severe nicotine dependence continue to smoke even while hooked up to a mobile oxygen tank or immediately after coronary bypass surgery.

Inhaled nicotine reaches the brain through the bloodstream in 10 to 20 seconds. It has a half-life of about 40 minutes and is metabolized primarily into cotinine in the liver. A single cigarette contains 8 to 9 milligrams of nicotine, and the probable acute fatal dose for an adult is 40 to 60 milligrams.

A man who continued to smoke while wearing several transdermal nicotine patches suffered cardiac arrest and died four days later in the hospital.

You must treat acute nicotine poisoning using specific emergency steps:

• Induce vomiting using syrup of ipecac to overcome acute nicotine poisoning.
• Perform gastric lavage, preferably followed by a slurry of activated charcoal left in the stomach.
• Initiate artificial respiration and treatment for shock if necessary.

Opioids and Endogenous Endorphins

Opioids relieve pain and produce euphoria through brain receptors normally affected by endogenous endorphins. Opiates come directly from the opium poppy, while synthetic opioids are manufactured to enhance potency. Most opioids exert their effects specifically as mu receptor agonists. Bayer Laboratories introduced heroin in 1898 as a nonaddicting pain reliever after adding two acetyl groups to the morphine molecule.

In the early 1970s, scientists discovered endogenous opiate receptors and natural peptides containing 31 amino acids in a beta-endorphin peptide. These include leucine-enkephalin, methionine-enkephalin, beta-endorphin, and dynorphins.

Plasma endorphin levels increase during running, which helps explain the runner's high reported by athletes.

Opiate use dates back approximately 6,000 years in Europe and the Middle East. Frederich Sertürner isolated morphium in 1806, and codeine was identified in 1832. The invention of the hypodermic syringe in the 1850s increased addiction rates known as soldier's disease among combat veterans.

Returning veterans from the American Civil War, Prussian-Austrian War, and Franco-Prussian War maintained their addictions because opiates were unregulated and available without a prescription.

Opioids decrease brainstem activity monitoring blood carbon dioxide and stimulate the vomit reflex. They trigger mast-cell degranulation and histamine release in the lungs, causing an anaphylactoid reaction with pulmonary edema. Between 1999 and 2006, US opioid overdose deaths nearly quadrupled from about 4,000 to nearly 15,000 deaths per year.

6. Cannabis, Inhalants, Hallucinogens, and Psychiatric Medications

Specialized drug classes ranging from cannabinoids and inhalants to antipsychotics and antidepressants modify diverse receptor systems.

Cannabis use dates back thousands of years across various civilizations for medicinal, industrial, and recreational purposes. SAMHSA data indicates that marijuana is the most prevalent illicit substance, with millions of past-month users.

George Washington grew Cannabis sativa on his farm in Mount Vernon, likely for making hemp rope, and early historical references date back to the Shen Nung dynasty in China in 2737 B.C. In 2006, estimated marijuana horticulture in the United States reached 35.8 billion dollars, alongside a 14 billion dollar estimated cash crop value in California in 2010. According to 2009 SAMHSA data, there were 16.7 million past-month marijuana users in the U.S. and a 6.6 percent past-month use rate among adolescents 12 or older.

Delta-9-tetrahydrocannabinol binds to specific G-protein brain receptors, producing alterations in mood, cognition, coordination, and memory.

Marijuana Pharmacology and Medical Uses

Modern marijuana varieties contain 3 to 22 percent THC concentration. A single joint produces a subjective high lasting approximately 2 hours, and 9 percent of users become addicted and experience craving. Animal projections show a 20,000-fold difference between a therapeutic dose of THC and a lethal dose.

Dronabinol or Marinol is prescribed as a Schedule II THC drug to control severe nausea and vomiting associated with cancer chemotherapy.

You can follow specific steps when managing cannabis-induced panic:

• First, determine if other intoxicating drugs or pre-existing medical disorders are contributing to the symptoms during a panic attack.
• Second, assure the patient that it is only a drug and the symptoms will stop in less than 5 to 8 hours.
• Third, decrease outside stimulation by placing the patient in a quiet room and talking them down.
• Fourth, reserve anxiolytics like alprazolam at 6 mg daily only if the panic reaction is completely uncontrollable.

Inhalants and Hallucinogens

Inhalants are volatile chemical solvents that enter the circulation rapidly via the pulmonary system, posing extreme risks of toxicity and sudden death. Young people utilize administration techniques such as huffing from a saturated cloth, bagging from a paper bag, snorting from a container, or ballooning with nitrous oxide. Data shows 15 percent of 8th graders, 12 percent of 10th graders, and 15 percent of high school seniors report having used inhalants. Blood concentrations of inhalants increase rapidly within a 10 to 20 second time frame.

Hallucinogens are categorized into two primary molecular structures that share a high affinity for brain serotonin receptors. Lysergic acid diethylamide is an extremely potent hallucinogen with rapid oral absorption and a high therapeutic index. A 25-year-old male died 16 hours after hospital admission in 1985 in a case directly attributed to LSD.

Antipsychotics and Antidepressants

Schizophrenia symptoms are strongly linked to abnormalities in brain dopamine systems, specifically through dopamine receptor abundance and overactivity. Antipsychotic medications are divided into typical and atypical categories, with newer atypical drugs acting largely as serotonin receptor antagonists to minimize movement side effects.

Long-term use of typical antipsychotics can induce four major extrapyramidal motor system disorders.

You must watch for distinct symptoms when monitoring these motor disorders:

• Pseudoparkinsonism: Watch for drooling, shuffling, pill-rolling finger movements, tremor, and rigidity developing 5 to 30 days after treatment.
• Tardive dyskinesia: Look for lip smacking, chewing, blowing, blepharospasm, bon-bon tongue movements, and choreoathetoid movements.
• Akathisias: Note feelings of restlessness where the patient is unable to sit comfortably without continuous motor activity.
• Acute dystonic reactions: Observe facial grimacing or muscle spasms of the tongue, face, neck, and back occurring within one to two weeks.

Antidepressants were discovered serendipitously in the 1950s when the tuberculosis drug iproniazid induced elation in patients, leading to the understanding that inhibiting monoamine oxidase elevates mood. Tuberculosis sanitariums used iproniazid, which unexpectedly caused elation in depressed patients long before they ever had tuberculosis. Antidepressants are categorized into specific generations and mechanisms, including MAOIs, tricyclics, SSRIs, SNRIs, and fast-acting agents like ketamine acting on glutamate receptors. Fluoxetine (Prozac) became a mainstay of antidepressant pharmacotherapy as a selective serotonin reuptake inhibitor.

7. Addiction and Forensic Toxicology

Chemical dependence stems from reward pathway dysregulation, while forensic toxicology calculates drug burdens and impairment levels.

Addiction and Chemical Dependence

Addiction is scientifically defined as chemical dependence characterized by impaired control over drug use driven by neurochemical dysregulation in the brain reward pathway. The primary symptom of chemical dependence is an inability to stop using a drug despite strong desire and negative consequences. This disease state stems from a dysregulation in the mesolimbic dopamine system.

An alcoholic vomits blood daily and has esophageal bleeding from alcohol use, yet still cannot stop drinking. Seven major neurotransmitters are involved in the reward pathway response: dopamine, serotonin, endorphins, GABA, glutamate, acetylcholine, and endocannabinoids. Each class of addicting drugs targets one or more of these systems. Cocaine, amphetamines, and alcohol act on dopamine, while opioids and alcohol act on endorphins.

Forensic Testing and Pharmacokinetic Calculations

Forensic psychopharmacology uses various sample types like blood, breath, serum, urine, and hair to detect drug presence, though detection alone does not prove intoxication or impairment. Blood testing directly measures drug concentration circulating to the brain, whereas urine testing detects drug metabolites based on half-life but cannot prove the subject was under the influence at the time of testing. Gas chromatography combined with mass spectroscopy is used in crime laboratories as the analytical gold standard to detect minute quantities of drugs. Radioimmunoassay hair testing can detect drug use for up to 90 days.

Pharmacokinetic equations utilizing volume of distribution, body weight, and plasma concentration can determine whether a detected drug amount reflects proper prescription use. A student with a blood test showing 0.02 mg/L of alprazolam, a body weight of 82 kg, and a Vd of 1 L/kg yields a circulating dose of 1.64 mg, indicating proper therapeutic use. Total body water algorithms and pharmacokinetic formulas enable forensic scientists to calculate alcohol consumption and debunk false claims about intake amounts. A 23-year-old woman weighing 110 pounds with a BAC of 0.08 percent claimed she consumed only one beer two hours earlier. Calculations proved her total body water and circulating alcohol burden equaled about 28 grams, meaning she consumed more than two beers.

• Calculate circulating dose using the formula D equals Vd multiplied by body weight in kilograms multiplied by the concentration of drug in plasma.
• Calculate total body water using the Watson algorithms based on gender, age, weight, and height.
• Calculate circulating alcohol burden using the blood alcohol concentration and total body water divided by the water content of blood.

10 Key Ideas

1. Psychoactive drugs alter human thoughts, feelings, and behavior by directly changing brain chemistry and functioning.
2. Historical views of the brain evolved from treating the mind and body as separate entities to recognizing that consciousness is entirely physical and rooted in nervous system activity.
3. All psychoactive drugs alter behavior by modifying the functional activity of neurotransmitters through specific cellular mechanisms at the synapse.
4. Pharmacokinetics determines drug onset, strength, and duration through circulation, barrier crossing, and elimination.
5. Alcohol produces a dose-dependent biphasic effect on human behavior, acting first as an upper and then as a downer.
6. Stimulants, nicotine, and opioids hijack the mesolimbic dopamine reward pathway to produce euphoria and chemical dependence.
7. Nicotine is a volatile alkaline substance that acts as both a stimulant and depressant by activating and desensitizing nicotinic acetylcholine receptors.
8. Opioids relieve pain and produce euphoria through brain receptors normally affected by endogenous endorphins.
9. Specialized drug classes ranging from cannabinoids and inhalants to antipsychotics and antidepressants modify diverse receptor systems.
10. Chemical dependence stems from reward pathway dysregulation, while forensic toxicology calculates drug burdens and impairment levels.